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A mechanistic model of the neural 
entropy increase elicited 
by psychedelic drugs
Rubén Herzog1*, Pedro A. M. Mediano2, Fernando E. Rosas3,4,5, Robin Carhart‑Harris3, 
Yonatan Sanz Perl6,7,8, Enzo Tagliazucchi6,7 & Rodrigo Cofre9
Psychedelic drugs, including lysergic acid diethylamide and other agonists of the serotonin 
2A receptor (5HT2A‑R), induce drastic changes in subjective experience, and provide a unique 
opportunity to study the neurobiological basis of consciousness. One of the most notable 
neurophysiological signatures of psychedelics, increased entropy in spontaneous neural activity, 
is thought to be of relevance to the psychedelic experience, mediating both acute alterations in 
consciousness and long‑term effects. However, no clear mechanistic explanation for this entropy 
increase has been put forward so far. We sought to do this here by building upon a recent whole‑brain 
model of serotonergic neuromodulation, to study the entropic effects of 5HT2A‑R activation. Our 
results reproduce the overall entropy increase observed in previous experiments in vivo, providing 
the first model‑based explanation for this phenomenon. We also found that entropy changes were 
not uniform across the brain: entropy increased in some regions and decreased in others, suggesting 
a topographical reconfiguration mediated by 5HT2A‑R activation. Interestingly, at the whole‑brain 
level, this reconfiguration was not well explained by 5HT2A‑R density, but related closely to the 
topological properties of the brain’s anatomical connectivity. These results help us understand the 
mechanisms underlying the psychedelic state and, more generally, the pharmacological modulation of 
whole‑brain activity.
Psychedelic drugs provide a privileged opportunity to study the mind-brain relationship, and promise to revo-
lutionise some of our current mental health  treatments1–3. However, while some aspects of the neurochemical 
action of psychedelics at the neuronal and sub-neuronal level are well  known4,5, our current understanding of 
their action at the whole-brain level is still very limited. A deeper understanding of the mechanisms that trigger 
the changes in conscious experience produced by psychedelics would greatly advance our knowledge of human 
consciousness, and medical development of psychedelics.
At a subjective level, serotonergic psychedelics (including lysergic acid diethylamide (LSD), dimethyl-
tryptamine [DMT] and psilocybin, among others) potentially modulate mood, cognition, perception and self-
awareness. At a neurophysiological level, recent research has identified (among many) two particularly prominent 
signatures of the psychedelic state: an overall dysregulation of neural population activity, most clearly seen as 
suppression of spectral power in the alpha (8–12 Hz)  band6–8; and an increase in the signal diversity of the neural 
activity, measured through the information-theoretic notion of  entropy9. In particular, this acute entropy increase 
has been linked to both short- and long-term effects of the psychedelic experience, including certain aspects of 
the reported subjective  experience9 and subsequent personality  changes10.
Interestingly, the opposite effects have been reported for states of loss of consciousness, where a strong 
decrease in brain entropy has been repeatedly observed. This seems to be a core feature of loss of consciousness, 
generalising across states such as deep  sleep11, general  anaesthesia12, and disorders of  consciousness13. Together, 
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these facts are yielding converging evidence that entropy and related measures offer simple and powerful indices 
of consciousness.
Based on these findings, Carhart-Harris and colleagues have put forward the Entropic Brain Hypothesis (EBH) 
an entropy-based theory of conscious  states1,14 The EBH proposes the simple, yet powerful idea that the variety 
of states of consciousness can be indexed by the entropy of key parameters of brain activity; or, in other words, 
that the richness of subjective experience is directly related to the richness of on-going neural activity, where 
richness can be defined most simply as diversity. Note that even when different states can be indexed by their 
corresponding diversity, we are not claiming that one state is more conscious than other. Therefore, investigat-
ing the neurobiological origins of such changes in brain activity is a key step in the study of altered states of 
consciousness.
Multiple experiments in humans and animal models have established that the mind-altering effects of psych-
edelics depend on agonism specifically at the serotonin 2A receptor (5HT2A-R)15–17. A recent simulation study 
involving whole-brain computational modelling confirmed that the topographic distribution of 5HT2A-R in 
the human brain is critical to reproduce the functional connectivity dynamics (FCD) of human fMRI data 
recorded under the acute effects of  LSD18. Here we build upon this model to characterise the interplay between 
the entropy of brain signals, the distribution of 5HT2A receptors, and structural connectivity properties of the 
brain, with the overarching goal of explaining the sources of entropic effects, and thus altered consciousness, 
elicited by psychedelic drugs.
Results
We simulated whole-brain activity using the Dynamic Mean-Field (DMF) model by Deco et al.19 using parameter 
values fit to reproduce the dynamics of fMRI recordings in humans during wakeful rest, as well as under the 
acute effects of  LSD18. The model consists of interacting pools of excitatory and inhibitory neural populations, 
coupled via long-range excitatory connections informed by the anatomical connectivity of the brain. The DMF 
model combines a theoretical model of neural and synaptic dynamics with two empirical sources of informa-
tion about the human brain: the human connectome, i.e. DTI-estimated connectivity between the 90 regions 
of the  AAL20 atlas; and average 5HT2A-R expression across the human brain obtained with Positron Emission 
Tomography (PET)  scans21.
Each simulation of the DMF model generates 90 time series of excitatory firing rates, one for each region 
of the AAL atlas (Fig. 1A). These excitatory firing rates have a non-linear dependency on the local excitatory 
inputs, determined by a frequency–current (F–I) curve. Given that 5HT2A-R seems to modulate the sensitivity 
Figure 1.  Modelling the effect of 5HT2A-R activation on the whole-brain topographical distribution of entropy. 
(A) Resting state activity is simulated using the Dynamic Mean-Field (DMF) model, in which each region’s 
activity is represented by a time series of excitatory firing rates (constrained to 0–15 Hz for visualisation). The 
probability density function (PDF) and differential entropy (h(X)) of each region is then estimated, obtaining 
a topographical distribution of entropy values. (B) 5HT2A-R agonism is modelled as a receptor-density-
dependent response gain modulation. Black line is the frequency–current (F–I) curve of a population without 
5HT2A-R agonism, and coloured curves show the resulting F–I curves of regions with increasing 5HT2A-R 
agonism. (C) 5HT2A-R activation changes the topographical distribution of entropy with respect to resting state 
activity, which constitutes the main subject of analysis in this study.
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of neurons rather than driving them towards excitation or  inhibition4,22,23, we followed Deco et al.18 and mod-
elled 5HT2A-R activation as a response-gain  modulation24 of this F–I curve dependent on the receptor density 
at a given region (Fig. 1B). We simulated the model in two conditions, with and without 5HT2A-R activation, 
which, in an analogy with neuroscientific terminology, we refer to as placebo (PLA) and 5HT2A-R conditions, 
respectively. In this way, we obtain 90 time series for each condition, which we keep for further analysis.
Finally, using these time series, we estimate Shannon’s differential entropy for each region under both condi-
tions, yielding a topographical distribution of entropy values (Fig. 1C) that constitutes the main subject of analysis 
in this study. Further details about model specification and entropy estimation, as well as other methodological 
caveats, are presented in the “Methods” section at the end of this article.
5HT2A‑R activation causes a heterogeneous, non‑linear increase in the entropy of sim‑
ulated brain activity. In our first analysis, we used the DMF model to test the main prediction of the 
EBH: that 5HT2A-R activation causes an increase in the overall entropy of neural signals (Fig. 2). In line with 
previous experimental findings with psychedelic  drugs9, the model shows a significant increase in the brain’s 
entropy h due to 5HT2A-R activation, with an average entropy of hPLA = 2.20 nat in the placebo condition, 
and h5HT2A = 2.30 nat in the 5HT2A-R condition (dashed vertical lines in Fig. 2B, Wilcoxon signed-rank test 
p < 10−6 , Cohen’s d = 0.262± 0.011 ). The average firing rates of regions, in turn, remained unchanged. A 
closer look at the distribution of entropy changes, however, reveals a more nuanced picture, with some regions 
increasing and some decreasing their entropy as a result of 5HT2A-R activation (Fig. 2D). This suggests that, 
according to the model, 5HT2A-R agonism might trigger a complex reconfiguration of the topographically spe-
cific distribution of entropy, and not a mere homogeneous overall increase.
Figure 2.  Non-linear heterogeneous increase of entropy following 5HT2A-R activation. (A) Effect of 5HT2A-R 
agonism on the local entropy each of region in the AAL atlas. See Supplementary Table 1 for abbreviations. 
Bars indicate the (bilateral) average relative change in local entropy, hn , and error bars indicate 1 standard 
deviation across 1000 simulations. (B) Histograms of local entropy values for the condition with (red) and 
without (blue) 5HT2A-R activation. 5HT2A-R activation increased both the average and the spread of the local 
entropy distribution. (C) Topographical map of entropy changes. Brain regions are coloured according to their 
hn values. (D) 5HT2A-R agonism changed the topographical distribution of entropy in a heavily non-linear 
manner. Each circle indicates the averages of each region across 1000 simulations.
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To investigate this reconfiguration, we analysed the local changes in entropy by plotting the entropy of the 
nth region in both PLA and 5HT2A conditions, denoted by h5HT2An  and hPLAn  respectively (Fig. 2D). Our results 
show that 5HT2A-R activation affects local entropy in a highly non-linear manner, especially in regions with low 
baseline resting state entropy. In particular, in such regions the effect of 5HT2A-R activation could either increase 
or decrease entropy, such that the local entropy in the 5HT2A-R condition could not always be determined by 
the region’s baseline entropy. This finding hints towards a more general theme: that local dynamical properties 
alone are not able to explain the local changes in activity induced by 5HT2A-R agonists like psychedelic drugs. 
We will explore this phenomenon in depth in the following sections.
Next, we studied the effect of 5HT2A-R agonism on local entropy by considering the relative change scores,
Based on recent in vivo experiments with serotonergic psychedelics we expect to find localized entropy increases 
on occipital, cingulate and parietal  regions9,10 as well as several changes on regions belonging to Resting State 
Networks (RSNs)7,25,26. Accordingly, we split brain regions by standard anatomical and functional groupings, and 
found that occipital and cingulate areas tend to show a strong relative increase in their entropy, while parietal 
and subcortical areas tend to show a decrease (Fig. 2A, Supp. Fig. 1). Additionally, regions participating in the 
primary visual and Default Mode (DMN) RSNs—including occipital and cingulate areas, respectively—showed 
a marked tendency to increase their entropy, while regions participating in the Frontoparietal Executive Network 
(FPN) showed the opposite behaviour. Further discussion about the relation between these results and recent 
in vivo experiments with psychedelic drugs is presented in the “Discussion” section.
The topography of entropy changes is explained by local connectivity strength and 5HT2A‑R 
density. Given the results above, and given the potential clinical and neuroscientific relevance of entropy 
reconfiguration in the psychedelic state, our next task is to elucidate what neurobiological factors underlie such 
phenomenon. In this section we investigate which structural and dynamical features of the model are able to 
predict local entropy changes due to 5HT2A-R activation, and what we can learn about the large-scale action 
mechanism of psychedelic drugs and other 5HT2A-R agonists.
To explain the effects of 5HT2A-R activation, the first natural step is to factor in the density of 5HT2A-R at 
each region. Somewhat surprisingly, at a whole-brain level, receptor density was a very poor predictor of the 
entropy change due to 5HT2A-R activation (Fig. 3A, R2 = 0.078± 0.004 ). In contrast, we found that the con-
nectivity strength (based on the DTI human connectome), defined as the sum of all the weighted links connecting 
a given region, exhibits a strong correlation with local entropy changes (Fig. 3B, R2 = 0.801± 0.006).
By visual inspection, however, it is clear that the relationship between DTI-informed connectivity strength 
and hn is linear for intermediate values of strength, but it departs from linearity in both extremes of the dis-
tribution. To investigate this phenomenon, we implemented a simple optimisation algorithm to find the set of 
regions with the strongest linear relationship between strength and hn . This yielded a set of regions with a 
higher strength-hn correlation ( R2 = 0.886± 0.007 , as opposed to R2 = 0.801± 0.006 for the whole-brain), 
and induced a partition of all brain regions into three groups: those with intermediate strength (IS, 76± 4 brain 
regions, grey dots in Fig. 3A), high strength (HS, 12± 3 regions, red dots), and low strength (LS, 2± 2 regions, 
blue dots).
Building up on this partition, we studied the effect of receptor density on those regions where entropy change 







Figure 3.  Changes in local entropy are explained best by connectivity strength, then receptor density. (A) 
Changes in entropy were overall independent from receptor density, although (B) they were well predicted by 
the connectivity strength of each region. We split into groups of low (blue), intermediate (grey) and higher (red) 
connectivity strength, only those regions with low and high connectivity strength were well predicted by their 
receptor density. Regions with intermediate strength show no significant relationship with receptor density, 
but are even more accurately predicted by their strength. (C) Topographical localisation of the three groups, 
following the same colour code. Low-strength regions are mainly located in the parietal area, while high-
strength ones are in occipital and cingulate areas.
5
Vol.:(0123456789)
Scientific Reports |        (2020) 10:17725  | https://doi.org/10.1038/s41598-020-74060-6
www.nature.com/scientificreports/
between receptor density and entropy changes for both the HS and LS groups, which resulted in positive 
( R2 = 0.95± 0.02 ) and negative ( R2 = 0.999± 0.001 ) correlation, respectively. On the contrary, receptor den-
sity does not predict entropy changes for areas in the IS category. This shows a complementary role of density 
and strength in LS, IS, and HS regions: entropy changes in HS and LS regions strongly depend on the receptor 
density, but not connectivity strength; while changes in IS regions depend on connectivity strength, but not 
receptor density.
Overall, to assess the predictive power of connectivity strength and the receptor density on local entropy 
changes, we built a linear mixed model for hn using connectivity strength, 5HT2A-R density, and the afore-
mentioned three-way separation of brain regions as the predictor variables. Together these variables explain 
95.91± 0.01% of the variance of hn , confirming that they provide an accurate model for predicting the entropic 
effects of 5HT2A-R activation. This suggests that psychedelic drugs and other 5HT2A-R agonists do not have a 
simple, localised effect on brain activity, but instead amplify the fundamentally collective, emergent properties 
of the brain as a complex system of interacting elements.
The specific connectivity strength distribution explains relative changes in entropy. As a 
final analysis, we set out to investigate exactly which topological properties of the brain’s structural connectiv-
ity explain the observed changes in entropy. With this exercise, we aim to answer two questions: whether any 
property simpler than connectivity strength can explain the results; and whether any property more complicated 
than connectivity strength is needed to do so.
To this end, we ran further simulations of the DMF model using suitable null network models of the human 
connectome (Fig. 4A), with the 5HT2A-R density map held fixed. In particular, we used three null models 
designed to test increasingly strict null hypotheses that preserved different network attributes of the original 
connectome: (1) the overall density and strength (RAND, Fig. 4B), (2) the degree distribution (degree-preserving 
randomisation [DPR], Fig. 4C); and (3) the strength distribution (strength-preserving randomisation, [DSPR], 
Fig. 4D). We simulated the DMF model in these surrogate networks, with and without neuromodulation, and 
computed the resulting entropy changes hn.
Our first result is that random and degree-preserving surrogate networks are unable to reproduce the entropy 
changes observed in the human connectome: when compared against the hn values obtained from the unper-
turbed network, neither of them produce values close to the original (Fig. 4E,F). This result asserts the findings 
in the previous section, showing that indeed node strength plays an important role in shaping the global pattern 
of entropy change associated with the action of psychedelics and other 5HT2A-R agonists. Simpler topological 
features, like the degree distribution, are not enough to explain such changes.
Perhaps more interestingly, the connectivity strength-preserving surrogate networks not only reproduced 
the entropy changes, but did so almost exactly (Fig. 4G). Furthermore, we repeated the analyses in the previous 
section trying to predict hn using other local connectivity measures (e.g. betweenness, eigenvector centrality), 
and none of them produced a model as accurate as strength (Supp. Fig. 2). Together, these results show that, once 
Figure 4.  Relative changes in entropy are reproduced by a strength-preserving null model of the connectome. 
(A)–(D) Connectivity matrices used to control the role of local properties of the connectome on hn . See 
main text for the description of the matrices and randomisation algorithm. (E)–(G). Scatter plots of hn for 
the human connectome against the three null models. DSPR yielded almost the same results than the human 
connectome, showing that only local network properties of human connectome are sufficient to capture the 
effect of 5HT2A-R activation.
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the receptor distribution is fixed, the network strength distribution is both necessary and sufficient to explain 
the entropic effects of 5HT2A-R activation. Of course, this is not to say that strength explains every aspect of 
5HT2A-R action—other topological network features are known to mediate transitions of consciousness in other 
 contexts27, and investigating which network properties explain high-order dynamical  signatures28 of psychedelics 
remains an exciting avenue of future work.
Discussion
In this study we investigated the brain entropy changes induced by serotonergic psychedelics by simulating 
whole-brain resting state activity with and without 5HT2A-R activation. In contrast to empirical studies, which 
usually only have access to coarse-grained fMRI or M/EEG data, our approach allows us to study firing rates of 
brain regions and hence to directly assess the effect of 5HT2A-R agonism at the level of neural population activity.
In agreement with the Entropic Brain  Hypothesis14, the model shows a significant increase of global brain 
entropy, albeit in a highly inhomogeneous and non-linear reconfiguration. The diversity of effects stresses the 
importance of extending the scope of the EBH from a simple level-based approach towards a multi-dimensional 
perspective, which might better characterise the richness of 5HT2A-R activation effect both on the brain and 
consciousness.
We propose a possible mechanism in the sense that the average increase in neural entropy induced by seroton-
ergic psychedelic drugs can be explained (in statistical sense) in terms of quantities that provide a neurobiological 
interpretation about how this phenomena could occur in the brain. These results have important consequences 
for our understanding of consciousness, neurodynamics, and the psychedelic state. In the following, we highlight 
some of those implications, and propose possibilities for future work.
5HT2A‑R‑induced entropy changes are regionally heterogeneous. Our main result in this study 
is a mechanistic explanation of the main prediction of the EBH that serotonergic psychedelics increase the 
entropy of brain activity. However, one of the main takeaways is that this overall increase is tied to a spatially 
heterogeneous reconfiguration, rather than a globally consistent increase, in entropy.
Our simulation results show that 5HT2A-R activation triggers an entropy increase in sensory areas, as 
observed in fusiform and olfactory cortices, as well as the primary visual RSN and occipital regions (Supp. 
Fig. 1). This agrees with the increased perceptual ‘bandwidth’ that characterises the psychedelic  state29, as higher 
entropy might be related to richer perceptual experience in a given moment of consciousness—potentially related 
to reduced gating. As a matter of fact, all the primary visual RSN regions (with the exception of the lingual area) 
are part of the high-strength group, suggesting that the effect of psychedelics on perceptual experience might 
be directly related to 5HT2A-R density in those regions. The localisation of the entropy increases may relate to 
domain-specific changes in consciousness, which could be interpreted as consistent with a recent dimensions 
of consciousness characterisation of the psychedelic  experience30.
Comparison to in vivo experiments with psychedelic drugs. Throughout the paper, we have focused 
on one particular signature of 5HT2A-R agonists on the brain—a global increase in average entropy. But much 
more is known about the effect of psychedelics on the brain, and studying these more nuanced effects is key to 
understanding the rich phenomenology of the psychedelic state. In this section we deepen this connection by 
providing a more detailed comparison between the behaviour of the model and experimental results with psy-
chedelic drugs.
Our findings are in agreement with earlier studies where the effect of psychedelic drugs on the topographical 
distribution of entropy-related measures was correlated with subjective effects. For example, Schartner et al.9 
studied the effect of LSD, psilocybin, and ketamine on the entropy rate of binarized MEG signals, and found 
localised increases in entropy rate on occipital and parietal regions. Similarly, Lebedev et al.10 analysed the sample 
entropy of fMRI recordings of subjects under the effect of LSD, finding localized increases on frontoparietal, 
medial occipital, posterior and dorsal cingulate regions. Many of those regions showed a consistent increase of 
their entropy with 5HT2A-R agonism in our study (Fig. 2A).
Moreover, many of those regions actually belong to the high connectivity strength group (c.f. Fig. 3), which 
suggests that their entropy increase in experimental data might be directly related to the high 5HT2A-R density 
in those regions. We speculate that regions of the high-strength group may systematically exhibit significant 
differences in local entropy on future experiments. Together, these findings support the conclusion that the 
DMF model, once optimised, can reproduce not only functional  connectivity18, but also some of the most salient 
localised entropy increases found on in vivo human studies up to date.
Also, on a more fundamental level, our findings suggest that psychedelics disrupt the functional organisation 
of the brain with an especially focal and pronounced action on highly anatomically connected brain regions. 
In fact, experimental and modelling evidence points towards a key role of connector hubs on psychedelic and 
psychopatological  states31,32. Perturbing the activity in these specific regions (via 5HT2A-R agonism) could have 
particularly profound implications for the regularity of brain activity and the quality of conscious experience. 
However, sub cortical regions may also play an important role on the modulation of brain activity, conscious 
experience, and the psychedelic  state33.
On a separate line of inquiry, there is strong evidence associating the DMN to high-level cognitive func-
tions, including the sense of space, time and recognition of (self) boundaries. Disruptions to the DMN have 
been linked to fundamental changes in experience, such as ego  dissolution14,34. Our simulation results show 
that 5HT2A-R activation increases the entropy of all DMN regions (with the exception of the angular cortex), 
which is consistent with the reported decrease in the DMN network  integrity31 induced by psychedelic drugs. In 
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contrast, low-level motor functions such as motor regulation remain largely unaffected during the psychedelic 
 state35, which is consistent with the modest entropy changes observed in the lingual and superior motor areas.
Finally, it is worth noting that both angular regions showed particularly important decreases in local entropy, 
specially in the left hemisphere (Fig. 2A). Damage to this region is associated with impairments on language 
processing, and electrical stimulation can induce out-of-body  experiences36 (both experiences can feature within 
psychedelic  states37). Since both structural damage and electrical stimulation can be related to entropy reduction 
(e.g. by stimulus-driven synchronisation), these experimental findings are consistent with the strong entropy 
decrease in angular regions predicted by the model.
We speculate that the reduced entropy observed on the angular region induced by 5HT2A-R agonism could 
be related to a smaller local bandwidth, which in turn might impair the multi-modal and integrative functions 
of this  region36.
Current limitations and future research. The approach employed in this work presents certain limita-
tions related to several aspects of the simulation and analysis. Acknowledging and understanding these limita-
tions can help us extend and improve our approach, while introducing new questions in the field of psychedelic 
computational neuroscience.
To our knowledge, the DMF model is the only whole-brain model that implements neuromodulation and 
is capable of reproducing neuroimaging data in the placebo and psychedelic states. Nonetheless, it makes some 
important simplifications that are worth discussing. At the network level, the DTI-based connectome used here 
is known to be incomplete, thus improvements could be made to the model parameters of brain  connectivity38. 
At the dynamical level, the DMF model models neuronal populations as perfectly homogeneous within a given 
region, and it is known that finer-grained local structure of certain brain regions is likely to be key to explaining 
certain subjective effects of the psychedelic state (e.g. lattice structure in the visual cortex and geometric visual 
 hallucinations39). Additionally, the version of the DMF model used here only considers 5HT2A-R agonism, 
while classic serotonergic psychedelic drugs also have high binding affinities for other receptors (e.g. in the case 
of LSD, the D1 and D2 dopamine  receptors40).
These simplifications do not prevent the model from reproducing statistical features of brain signals under 
the placebo and 5HT2A-R conditions, but could result in an inability to reproduce finer aspects of the dynamics 
of the whole-brain activity in these conditions. Extending the model to reproduce other dynamical signatures 
of psychedelics (like alpha suppression 8 or reduced directed functional connectivity 41) constitutes a natural 
extension of this work, with the recent example of Kringelbach et al. 42, where an extension of the DMF can 
reproduce dynamical features of the brain in placebo and in the psychedelic state.
Another potentially fruitful line of future work involves making more detailed comparisons with in vivo 
psychedelic neuroimaging data, and, potentially, subjective experience reports. For example, one natural option 
would be to use forward models of  fMRI43 or M/EEG44 to bridge between the firing rates produced by the DMF 
model and other data modalities, to produce simulated data that is more directly comparable with available 
empirical data.
Another exciting possibility is to explore model parameters to examine potential non-linearities and their 
implications for different relevant aspects of brain function. For example, there are reasons to believe that the 
dose-response relationship is non-linear for psychedelics and that over a certain threshold dosage (level of 
5HT2A-R stimulation) new subjective and global brain function properties can  appear45.
Most interestingly, a potentially very useful extension of this work would be to include individual subject-
level connectome and receptor data to build personalised models of response to psychedelic drugs. This would 
enable a much more comprehensive modelling framework, capable of correlating structural brain features with 
subjective experience reports. Such a framework could potentially make individualised predictions of the action 
of serotonergic psychedelics on specific individuals, aiding patient stratification and treatment  customisation2.
Finally, it is worth noting that all our analyses here are based on the univariate statistics of individual brain 
regions, not including any correlation or information flow between them. However, it is known that some high-
level subjective effects of psychedelics (such as complex  imagery7 and ego  dissolution34) are related to network, 
as opposed to single region, dynamics. Therefore, building a richer statistical description of the brain’s dynamics 
using recent information-theoretic tools (such as multivariate extensions of mutual  information28 or Integrated 
Information Theory,  IIT46) remains an exciting open problem. In fact, recent attempts of unifying IIT and the 
EBH in a single framework to understand the effects of psychedelic  drugs47 are helping to bridge the gap between 
the univariate EBH and the multivariate IIT.
Final remarks. In this paper we have provided the first mechanistic explanation of the neural entropy 
increase elicited by psychedelic drugs, using a whole-brain dynamical model with 5HT2A-R neuromodula-
tion. Furthermore, we built a simple linear model able to predict a region’s relative change in entropy from its 
local 5HT2A-R density and topological properties, showing that, somewhat paradoxically, at a whole-brain level 
receptor density is a poor predictor of 5HT2A-R activation effect.
Key to developing this predictive model was a three-way partition of brain regions according to their con-
nectivity strength, suggesting a differentiated action mechanism of 5HT2A-R agonists that depends on the local 
topology of brain regions. In summary, our results suggest that the local changes in entropy, as well as the global 
entropy increase, induced by 5HT2A-R activation can be explained from a region-specific interplay between 
structural connectivity and receptor density. Finally, controlled experiments with null network models confirm 
that receptor density and connectivity strength are not only necessary, but also sufficient, to explain the entropic 
effects of 5HT2A-R activation.
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The spatially heterogeneous, complex nature of the observed effects of 5HT2A-R activation opens a chal-
lenging problem for understanding the clinical and scientific relevance of psychedelic drugs and their entropic 
effect. Furthermore, it stresses the necessity of moving beyond the current unidimensional approach to con-
sciousness to a multi-dimensional one, that better captures the phenomenological and neurodynamical richness 
of psychedelic state.
Methods
Dynamic mean‑field model with 5HT2A‑R neuromodulation. The main computational tool used 
in this study is the Dynamic Mean-Field (DMF) model by Deco et al.18,19, which consists of a set of coupled 
differential equations modelling the average activity of one or more interacting brain regions. In this model, 
each brain region n is modelled as two reciprocally coupled neuronal masses, one excitatory and one inhibitory, 
and the excitatory and inhibitory synaptic currents I(E) and I(I) are mediated by NMDA and  GABAA receptors 
respectively. Different brain regions are coupled via their excitatory populations only, and the structural con-
nectivity is given by the matrix C.
The full model, including the neuromodulatory effect described below, is given by
Above, for each excitatory (E) and inhibitory (I) neural mass, the quantities I(E,I)n  , r(E,I)n  , and S(E,I)n  represent its 
total input current (nA), firing rate (Hz) and synaptic gating variable, respectively. The function F(·) is the transfer 
function (or F–I curve), representing the non-linear relationship between the input current and the output firing 
rate of a neural population. Finally, JFICn  is the local feedback inhibitory control of region n, which is  optimized19 
to keep its average firing rate at approximately 3Hz , and vn is uncorrelated Gaussian noise injected to region n. 
The interested reader is referred to the original publication for further  details19.
Key to this study is the recent extension of this model including neuromodulatory  effects18. In the equations 
above, gNMn  is a neuromodulatory scaling factor modulating the F–I curve of all brain regions in the model, which 
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Table 1.  Dynamic mean field (DMF) model parameters.
Parameter Symbol Value
External current I0 0.382 nA
Excitatory scaling factor for I0 WE 1
Inhibitory scaling factor for I0 WI 0.7
Local excitatory recurrence w+ 1.4
Excitatory synaptic coupling JNMDA 0.15 nA
Threshold for F(I(E)n ) I(E)thr 0.403 nA
Threshold for F(I(I)n ) I(I)thr 0.288 nA
Gain factor of F(I(E)n ) gE 310 nC−1
Gain factor of F(I(I)n ) gI 615 nC−1
Shape of F(I(E)n ) around I(E)thr dE 0.16 s
Shape of F(I(I)n ) around I(I)thr dI 0.087 s
Excitatory kinetic parameter γ 0.641
Amplitude of uncorrelated Gaussian noise vn σ 0.01 nA
Time constant of NMDA receptor τNMDA 100 ms
Time constant of GABA-A receptor τGABAA 10 ms
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affects region n depending on its density of the receptor of interest, drecn  . Including neuromodulation, the free 
parameters of the model are G, the global coupling parameter, and sE , the excitatory neuromodulatory gain, 
that are set to 2 and 0.2 respectively following Deco et al.18 The model was simulated using a standard Euler-
Maruyama integration  method48, using the parameter values shown in Table 1.
Parcellation, connectome, and 5HT2A receptor maps. In addition to the DMF equations above, 
to simulate whole-brain activity we need three more ingredients: a suitable parcellation of the cortex into well-
defined regions, a structural connectivity matrix between those regions, and the density map of a receptor of 
interest—in our case, the serotonin 2A receptor. We clarify that all the empirical inputs of the model were pro-
duced elsewhere. For a detailed description of the procedure, please follow the corresponding references cited 
below.
As a basis for our simulation, we used the Automated Anatomical Labelling (AAL)  atlas20, a sulci-based 
parcellation of brain volume registered in MNI space. The AAL parcellation specifies a partition of the brain 
into 90 Regions Of Interest (ROIs), that provides sufficient level of detail to obtain a picture of the topographical 
distribution of entropy, while being suitable for computationally intensive simulations.
Structural connectivity data between the 90 AAL ROIs was obtained from 16 healthy subjects (5 female) 
using diffusion Magnetic Resonance Imaging (dMRI), registered to the MNI space and parcellated according 
to the AAL atlas on the subject’s native space. Then, for each subject the histogram of fiber directions at each 
voxel was obtained, yielding an estimate of the number of fibers passing trough each voxel. The weight of the 
connection between regions i and j was defined as the proportion of fibers passing through region i that reach 
region j, which (since the directionality of connections cannot be determined using dMRI) yields a symmetric 
90× 90 Structural Connectivity (SC) matrix. Finally, the SC matrix of each subject was thresholded, pruning 
any connection lower than 0.1%, and SC matrices of all subjects were averaged to obtain a single SC matrix used 
in all simulations. This average matrix was kindly provided by Deco et al.18 For a detailed description of these 
methods see or refer to the Supplementary Subsection 7.
For the density map of 5HT2A receptors, we used the Positron Emission Tomography (PET) data made public 
by Beliveau et al.21, which can be combined with the AAL parcellation to obtain an estimate of receptor density 
in every AAL region. Further details can be found in the original  publications18,21.
Together with the DMF equations, these three elements fully specify our whole-brain model and allow us to 
run simulations and obtain time series of excitatory firing rates, r(E)n  , which we save for further analysis.
Estimating the differential entropy of firing rates. The result of each simulation is a set of 90 time 
series representing the firing rate of each excitatory population ( r(E)n  ), which we analysed to measure the entropy 
of the activity of each ROI. For a continuous random variable X with associated probability distribution p(x) and 
support X  , its differential entropy is defined  as49
Estimating differential entropy from data is in general a hard problem, stemming (for the most part) from the 
difficulties in estimating a probability density from  samples50. We found that the probability distributions of firing 
rates r(E)n  were well approximated by a gamma distribution: goodness-of-fit, measured with a standard Kolmogo-
rov–Smirnov statistic, was satisfactory and comparable across brain regions and conditions (see Supp. Fig. 3).
This observation greatly simplifies the estimation of the differential entropy of each region, which is now 
reduced to estimating the shape and scale parameters of the gamma distribution, k and θ . Once these parameters 
are estimated (in our case by standard maximum likelihood estimation), the differential entropy of a gamma 
distribution can be computed analytically in closed form as
where Ŵ(·) and ψ(·) are the standard gamma and digamma functions, respectively.
Linear models for h
n
 and three‑way separation of AAL regions. To explain the changes in dif-
ferential entropy across regions and conditions, we trained several linear mixed-effects  models51 using different 
sets of covariates designed to test specific hypotheses about the relation between entropy, 5HT2A-R density, and 
network topology.
First, we implemented a simple algorithm to find the group of regions where the change in entropy depends 
linearly on region strength. To do so, we designed an optimisation procedure to find the optimal linear fit between 
hn and connectivity strength after the removal of some regions from the fit by setting a threshold on hPLAn  . The 
procedure consisted in iteratively (1) setting a threshold on hPLAn  ; (2) fitting a linear model with strength as a 
regressor and hn as target for those regions below the threshold; and (3) computing the goodness of fit measured 
by R2 . This process is repeated for the whole range of entropy values, yielding one R2 value per threshold. The 
threshold that maximises goodness of fit gives the optimal separation between regions, separating those regions 
whose change in entropy linearly depends on connectivity strength from those that it does not.
With this three-way grouping fixed, we investigated the power of several dynamical and topological features 
to explain the changes in local entropy ( hn ) by including them as covariates in the linear model. The three-way 
separation of brain regions induces a model with 7 terms: a constant term and 2 fixed-effect terms for each group 
of regions: one for the connectivity strength and one for the receptor density. The model was fit by maximum 




p(x) ln p(x) dx.
h(X) = k + ln θ + lnŴ(k)+ (1− k)ψ(k),
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Null network models of the human connectome. Null network models of the human structural con-
nectivity were used to evaluate the role of the local connectivity  properties52 on the local changes in entropy 
induced by 5HT2A-R activation. To this end, we applied three different randomisation schemes to the structural 
connectivity in order to produce suitable surrogate networks. These surrogates were designed to preserve differ-
ent network attributes of the original connectome: (1) the overall density and strength (RAND), (2) the degree 
distribution (degree-preserving randomisation [DPR]); and (3) the strength distribution (strength-preserving 
randomisation [DSPR]).
After randomisation, the DMF model was run with and without 5HT2A-R activation, and entropies estimated 
and analysed following the same procedure as in the rest of the article. Every surrogate model was run 120 times, 
and the results averaged across runs.
In addition to the network surrogates, we computed several topological measures to include in the linear 
model reported in Fig. 3. These measures included betweenness, eigenvector centrality, closeness, communica-
bility, PageRank index, and sub-graph centrality. All of these computations, including the surrogate networks 
and the topology measures, were performed using the Brain Connectivity  Toolbox53.
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